Oncostatin M in combination with tumor necrosis factor α induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo
Open Access
- 8 December 2003
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (12) , 3404-3418
- https://doi.org/10.1002/art.11333
Abstract
Objective To determine the effects of the proinflammatory cytokine combination of oncostatin M (OSM) and tumor necrosis factor α (TNFα) on cartilage destruction in both in vitro and in vivo model systems. Methods The release of collagen and proteoglycan was assessed in bovine cartilage explant cultures, while messenger RNA (mRNA) from bovine chondrocytes was analyzed by Northern blotting. Immunohistochemistry was performed on sections prepared from murine joints following injection of adenovirus vectors encoding murine OSM and/or murine TNFα. Results The combination of OSM + TNFα induced significant collagen release from bovine cartilage, accompanied by high levels of active collagenolytic activity. Northern blot analysis indicated that this cytokine combination synergistically induced matrix metalloproteinase 1 (MMP-1), MMP-3, and MMP-13 mRNA. The in vivo data clearly indicated that OSM + TNFα overexpression increased MMP levels and decreased levels of tissue inhibitor of metalloproteinases 1 (TIMP-1). Specifically, OSM + TNFα induced marked synovial hyperplasia, inflammation, and cartilage and bone destruction with a concomitant increase in MMP expression in both cartilage and synovium and decreased TIMP-1 expression in the articular cartilage. These effects were markedly greater than those seen with either cytokine alone. Conclusion This study demonstrates that OSM + TNFα represents a potent proinflammatory cytokine combination that markedly induces MMP production in both cartilage and synovium, thus promoting joint destruction.Keywords
This publication has 50 references indexed in Scilit:
- Transforming growth factor β1 and insulin-like growth factor 1 block collagen degradation induced by oncostatin M in combination with tumour necrosis factor α from bovine cartilageAnnals of the Rheumatic Diseases, 2003
- The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasisTrends in Cell Biology, 2001
- The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradationOsteoarthritis and Cartilage, 2001
- Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdownArthritis & Rheumatism, 2001
- The inhibition of metalloproteinases as a therapeutic target in rheumatoid arthritis and osteoarthritisCurrent Opinion in Pharmacology, 2001
- Adenovirus Vector Expressing Mouse Oncostatin M Induces Acute-Phase Proteins and TIMP-1 ExpressionIn Vivoin MiceJournal of Interferon & Cytokine Research, 1999
- Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNFαGene Therapy, 1997
- Osteoarthritic Lesions. Involvement of three different collagenasesArthritis & Rheumatism, 1997
- Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.Journal of Clinical Investigation, 1997
- Induction of an acute erosive monarticular arthritis in mice by interleukin‐1 and methylated bovine serum albuminArthritis & Rheumatism, 1990